Core Viewpoint - A class action lawsuit has been filed against Charming Medical Limited for alleged violations of securities laws, specifically related to misleading statements made by the company during a specified class period [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from October 21, 2025, to November 12, 2025 [2]. - The lawsuit claims that Charming Medical made false and misleading statements that led to the suspension of trading of its shares by the SEC due to an investigation into a scheme to artificially inflate the company's share price [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although being appointed as lead plaintiff is not necessary to participate in any recovery [2]. - The deadline for participation in the lawsuit is set for February 17, 2026 [2]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents some of the largest hedge funds and alternative asset managers, indicating a strong reputation in the field [4].

LOS ANGELES--(BUSINESS WIRE)---- $MCTA--MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm. ...

Core Viewpoint - A securities fraud class action lawsuit has been filed against Charming Medical Limited on behalf of investors who acquired its securities during the specified class period [1] Group 1 - The lawsuit pertains to investors who purchased or acquired Charming Medical Limited securities between October 10, 2025, and November 12, 2025 [1] - Investors have until February 17, 2026, to file a lead plaintiff motion [1]

LOS ANGELES, Dec. 26, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com. Inte ...

Core Viewpoint - A class action has been filed on behalf of investors who purchased Charming Medical, Limited (NASDAQ: MCTA) securities between October 10, 2025, and November 12, 2025, indicating potential legal issues for the company [1]. Company Overview - Charming Medical, Limited aims to enhance quality of life by integrating Traditional Chinese Medicine (TCM) wellness practices with modern technology [1].

Core Viewpoint - A class action lawsuit has been filed against Charming Medical Limited (NASDAQ: MCTA) due to allegations of securities fraud during a specific class period from October 10, 2025, to November 12, 2025, with a deadline for lead plaintiff motion set for February 17, 2026 [1][4]. Group 1: Lawsuit Details - The lawsuit alleges that Charming Medical Limited made materially false and misleading statements and failed to disclose adverse facts about its business and operations [4]. - Specific allegations include involvement in a fraudulent stock promotion scheme using social media misinformation and impersonation of financial professionals [4]. - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, and that the company's public statements omitted mention of false rumors and artificial trading activity [4]. Group 2: SEC Involvement - On November 11, 2025, the SEC halted trading of Charming securities due to potential manipulation linked to social media recommendations aimed at inflating the stock price and trading volume [3].

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruzannounces that a class action lawsuit has been filed on behalf of shareholders who purchased Charming Medical Limited ("Charming†or the "Company†) (NASDAQ: MCTA) securities between October 10, 2025 and November 12, 2025, inclusive (the "Class Period†). Charming investors have until February 17, 2026 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS ON YOUR CHARMING MEDICAL LIMITED (MCTA), INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POT ...

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers Charming Medical Ltd. (NASDAQ: MCTA) (“Charming”) that a federal securities class action has been filed on behalf of investors who purchased Integer between October 21, 2025 and November 12, 2025, inclusive (the “Class Period”). Investors have until February 17, 2026 to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION The filed complaint ...

LOS ANGELES, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Charming Medical Limited, (“Charming Medical” or the "Company") (NASDAQ: MCTA) investors off a class action on behalf of investors that bought securities between October 21, 2025, and November 12, 2025, inclusive (the “Class Period”). Charming Medical investors have until February 17, 2026 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoyla ...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Charming Medical Limited ("Charming†or the "Company†) (NASDAQ: MCTA) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHARMING MEDICAL LIMITED (MCTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happen. ...